-
Mashup Score: 3
Previous studies have identified an interaction between protein kinase inhibitors (PKIs) and proton pump inhibitors (PPIs) in patients with lung cance…
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Tiny robot could stop bleeding from inside the body using heat - 2 month(s) ago
A small robot that can shape-shift and produce heat could incinerate cancer cells or stop bleeding from inside the body. It could also be used to ferry drugs…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet-
No evidence of bleeding. Patient can return to normal activities. https://t.co/It8GEXgKff
-
-
Mashup Score: 1
Daily – Tongue Cleaning and Lozenge. Weekly – Mouthwash
Source: www.amazon.comCategories: General Medicine News, Hem/OncsTweet-
@AaronGoodman33 Adding to my smart phrases😀 It is on amazon: https://t.co/ydkYrcgkgx
-
-
Mashup Score: 9First-Line Osimertinib for Uncommon EGFR Mutations and NSCLC - 3 month(s) ago
This nonrandomized phase 2 clinical trial assesses the usefulness of osimertinib in previously untreated patients with metastatic non–small cell lung cancer (NSCLC) harboring uncommon EGFR mutations, excluding exon 20 insertion mutations.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
First-Line Osimertinib for pts wt NSCLC and Uncommon EGFR Mutations #UNICORN trial 🦄 ❌excluding exon 20 👉ORR of 55.0% 👉mPFS of 9.4 months 👉mDoR of 22.7 months 👉mOS pending Very important trial, good to have this data! https://t.co/No7wruI6Vd
-
-
Mashup Score: 2
Progressive Ladies Welfare Association.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
2.5mg vs 10mg olanzapine is non inferior in #CINV control with better AEs profile. https://t.co/Y3wcPPpLdD
-
-
Mashup Score: 5Healthcare Unfiltered on Apple Podcasts - 1 year(s) ago
Science · 2023
Source: Apple PodcastsCategories: Hem/Oncs, Latest HeadlinesTweet-
High quality T-shirt from high quality podcast #HealthcareUnfiltered Thank you @chadinabhan for all you do and for the T-Shirt! 🙏 Yey!! Feel so happy!! Definitely check this amazing and eye-opening podcast ❗️ 👉 https://t.co/mej2VQ9iG0 https://t.co/pmPjXV34dv
-
-
Mashup Score: 0The Tail End — Wait But Why - 1 year(s) ago
No matter what your age, you may, without realizing it, be enjoying the very last chapter of the relationships that matter most to you. Make it count.
Source: Wait But WhyCategories: Hem/Oncs, Latest HeadlinesTweet-
Cool perspective! 👍🏼 The Tail End — Wait But Why https://t.co/PULKjialjt
-
-
Mashup Score: 1Toxic Exposure - 1 year(s) ago
Check out this great listen on Audible.com. A behind-the-scenes look inside three key trials involving Monsanto’s weed killer Roundup, cancer, and the search for justice—written by an expert witness medical oncologist who lived it all. For years, Monsanto declared that their product Roundup,…
Source: Audible.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Just finished ‘Toxic Exposure’ audiobook narrated by @chadinabhan himself - felt as convo with him at Starbucks! Dr.Nabhan's experiences in court as an expert, personal touch of his story coming to the US, career & family dynamics made it a great story! https://t.co/IG8R4Vrgvo
-
-
Mashup Score: 0İftar Paketimizin Hazırlanışını Nasıl Buldunuz? - 1 year(s) ago
—–AĞABABA PAKET iFTAR MENÜSÜ—–🛎İFTARİYELİKLER: Hurma, Zeytin, Çorba🍽ANA YEMEK: Karışık Izgara*ARA SICAK: İçli Köfte🥗SALATA: Çoban Salata*:MEZE: Çiğ …
Source: YouTubeCategories: Hem/Oncs, Latest HeadlinesTweet-
Just regular Turkish fast food 👍🏼👌🇹🇷 https://t.co/ff6wLUanYO
-
-
Mashup Score: 0
Vinay Prasad, MD MPH; Physician & Professor Hematologist/ OncologistProfessor of Epidemiology, Biostatistics and MedicineAuthor of 450+ Peer Reviewed papers,…
Source: YouTubeCategories: Hem/Oncs, Latest HeadlinesTweet-
Strongly recommend this awesome review by @VPrasadMDMPH to all #HemeOnc #Fellows! Very educational on so many aspects of clinical trial design and interpretation! #PFS #OS #Censoring #Crossover #bonus ➡️ good sense of humor ...read book #Malignant‼️ https://t.co/zGhdo1JVJU
-
In lights of recent retrospective data from on EGFR TKIs use with PPIs showing negative outcomes in NSCLC pts, would you consider d/c PPIs or changing to H2?@StephenVLiu @NarjustFlorezMD @CharuAggarwalMD @HosseinBorghaei https://t.co/BJL7CWydjO